Global Prosthetic Heart Valve Market By Type (Mechanical heart valves, (Bileaflet, Monoleaflet, Caged ball valves), Tissue(bioprosthetic) heart valves (Stented, Stentless), Transcatheter heart valves) By Position (Arotic, Mitral) By End Users (Hospitals and Clinics, Ambulatory Centers, Urgent Care Centers, Speciality Cardiac Centers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
A prosthetic heart valve is a device that is implanted in a patient who has valvular heart disease, a condition in which one or more of the heart's valves fail. The replacement of a natural heart valve with a prosthetic one is used to treat this issue, which minimises the mortality and morbidity associated with cardiac valve abnormalities. The rising prevalence of valvular heart disease is a global therapeutic issue, with 850,000 people likely to need therapies by 2050. Surgically implanted mechanical heart valves (MHVs) and biological heart valves are the two most popular types of prosthetic heart valves utilised to address this condition. BHVs can be transplanted surgically or using a minimally invasive transcatheter method. According to the American College of Cardiology, about 5 million people in the United States are diagnosed with HVD each year. Due to calcium accumulation and scarring in the valve cusp induced by ageing, VHD primarily affects the elderly. As a result, the rising ageing population and the resulting rise in VHD cases are expected to drive the global prosthetic heart valves market forward in the coming years. The prosthetic valves sector has witnessed several clinical investigations in recent years, notably in Europe, due to consistent standards and the high occurrence of heart problems. Thus with the advancements the global prosthetic heart valve market is expected to grow rapidly during the forecast years.
In terms of revenue, global prosthetic heart valve market was valued at US$ 6.98 Bn in 2021 growing at a CAGR of 11.1% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Prosthetic Heart Valve Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
Based on the type segment, the global prosthetic heart valve market is segmented into three different types such as mechanical valves come in a variety of materials and shapes, including stainless steel, pyrolitic carbon, and ceramic, as well as caged-ball, monoleaflet, and bileaflet. They are structurally sound and have a long service life. Secondly biological aortic valves are made of biological tissue that can be xenogenic (bovine or porcine) or allogenic (homograft), stented or stentless, and last 10–15 years. Durability is a difficulty with these valves. Tissue heart valves, also known as transcatheter or percutaneous aortic valves, come in two types: balloon-expandable and self-expandable. They are introduced percutaneously and are simple to implant, however they do not survive as long as surgical bioprosthesis. Biological aortic valves are widely gaining popularity due to the advancements. For instance, Edwards Lifesciences introduced state-of-the-art Resilia bovine pericardial bioprosthetic tissue. This valve is said to provide anti-calcification qualities, as well as improved sustained hemodynamic performance and longevity, lowering the risk of reoperation. Furthermore there are various challenges for the prosthetic heart valve surgeries which has led to the urgency of developing ad improving their design and biocompatibility and durability. Hence with these advancements in the heart valves is anticipated to support the growth of global prosthetic heart valves market during the forecast period.
End User Outlook
Based on the end user segment, the global prosthetic heart valve market is segmented into hospitals and clinics, ambulatory surgical centers, urgent care center, speciality cardiac centers and others which include specialty centers, research & academic institutes. In the last few years, research & academic institutes are keenly looking forward to the advancements that can be incorporated for the designs of the prosthetic valves. For instance, Caltech researchers have assisted in the development of a new generation of heart valves that are more biocompatible, last longer, and cost less to manufacture than current options. In late of 2019, one of the novel valves was implanted for the first time in a patient as part of an FDA trial. The Tria valve combines a revolutionary biopolymer material with a bioinspired design to create a valve that can endure decades without calcification, clotting danger, or red blood cell damage. In testing, one valve has already endured 600 million cycles, or almost 15 years, without showing any symptoms of wear and tear. Furthermore ambulatory surgical centers are on the rise as ambulatory surgical centers often provide a more comfortable, convenient, and patient-centered experience than traditional outpatient hospital settings. For patients, providers, and insurers, ASCs are often more cost-effective than hospitals. Thus with the rise in research for prosthetic heart valves by various academic institutes has led to the growth of global prosthetic heart valve market.
Region Outlook
Based on the regions, North America has the highest share in the prosthetic heart valve market in the year 2021. The major driving factors for the prosthetic heart valve market in United States and Canada is the rise in geriatric population suffering from various heart-related diseases. Moreover in the last few years, due to lifestyle and dietary changes there has been rise in heart related disease amongst the younger generations as well. Leading players in the market are focused on investing into research and development to introduce various instruments and devices to cater the rising demand. Furthermore the high cost associated with the prosthetic heart valves, strict regulations for the FDA approval process for the launch of new products were a hindrance to the growth of the market. But on the other hand rising initiative by the government and healthcare organizations for supporting the heart valve surgeries has led to the growth of the prosthetic heart valves market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global prosthetic heart valve market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global prosthetic heart valve market are mentioned below:
- Abbott
- Braile Biomédica
- Colibri Heart Valve
- CryoLife, Inc
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc.
- Labcor
- LivaNova PLC( Gyprus Capital)
- Medtronic
- Other Industry Participants
Global Prosthetic Heart Valve Market:
By Type
- Mechanical heart valves
- Bileaflet
- Monoleaflet
- Caged ball valves
- Tissue(bioprosthetic) heart valves
- Stented
- Stentless
- Transcatheter heart valves
By Position
- Arotic
- Mitral
By End Users
- Hospitals and clinics
- Ambulatory centers
- Urgent care centers
- Speciality Cardiac Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Prosthetic Heart Valve Market
6. Market Synopsis: Prosthetic Heart Valve Market
7. Prosthetic Heart Valve Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Prosthetic Heart Valve Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Prosthetic Heart Valve Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Prosthetic Heart Valve Market
8. Global Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1. Global Prosthetic Heart Valve Market Revenue (US$ Mn)
8.2. Global Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Mechanical heart valves (Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Bileaflet, Monoleaflet , Caged ball valves)
8.2.1.1. Bileaflet
8.2.1.2. Monoleaflet
8.2.1.3. Caged ball valves
8.2.2. Tissue(bioprosthetic) heart valves (Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Stented , Stentless )
8.2.2.1. Stented
8.2.2.2. Stentless
8.2.3. Transcatheter heart valves
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2020
8.2.3.3. Market Forecast, 2022 - 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market Estimation, 2015 - 2020
8.2.3.5.1.2. Market Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2020
8.2.3.5.2.2. Market Forecast, 2022 - 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2020
8.2.3.5.3.2. Market Forecast, 2022 - 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2020
8.2.3.5.4.2. Market Forecast, 2022 - 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market Estimation, 2015 - 2020
8.2.3.5.5.2. Market Forecast, 2022 - 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9. Global Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
9.2.1. Arotic
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2022 - 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 - 2020
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2020
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2020
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2020
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 - 2020
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2. Mitral
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2022 - 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market Estimation, 2015 - 2020
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2020
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2020
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2020
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market Estimation, 2015 - 2020
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Position
10. Global Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
10.1. Overview
10.2. Global Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
10.2.1. Hospitals and clinics
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2022 - 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2020
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2020
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2020
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2020
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2020
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Ambulatory centers
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2022 - 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2020
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2020
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2020
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2020
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2020
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Urgent care centers
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2022 - 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2020
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2020
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2020
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2020
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2020
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Speciality Cardiac Centers
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2020
10.2.4.3. Market Forecast, 2022 - 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2020
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2020
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2020
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2020
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2020
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2020
10.2.5.3. Market Forecast, 2022 - 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 - 2020
10.2.5.5.1.2. Market Forecast, 2022 - 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2020
10.2.5.5.2.2. Market Forecast, 2022 - 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2020
10.2.5.5.3.2. Market Forecast, 2022 - 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2020
10.2.5.5.4.2. Market Forecast, 2022 - 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 - 2020
10.2.5.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By End Users
11. North America Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. North America Prosthetic Heart Valve Market Revenue (US$ Mn)
11.2. North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
11.2.1. Mechanical heart valves
11.2.1.1. Bileaflet
11.2.1.2. Monoleaflet
11.2.1.3. Caged ball valves
11.2.2. Tissue(bioprosthetic) heart valves
11.2.2.1. Stented
11.2.2.2. Stentless
11.2.3. Transcatheter heart valves
11.3. North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
11.3.1. Arotic
11.3.2. Mitral
11.4. North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.1. Hospitals and clinics
11.4.2. Ambulatory centers
11.4.3. Urgent care centers
11.4.4. Speciality Cardiac Centers
11.4.5. Others
11.5. North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
11.5.1.1.1. Mechanical heart valves
11.5.1.1.1.1. Bileaflet
11.5.1.1.1.2. Monoleaflet
11.5.1.1.1.3. Caged ball valves
11.5.1.1.2. Tissue(bioprosthetic) heart valves
11.5.1.1.2.1. Stented
11.5.1.1.2.2. Stentless
11.5.1.1.3. Transcatheter heart valves
11.5.1.2. U.S Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
11.5.1.2.1. Arotic
11.5.1.2.2. Mitral
11.5.1.3. U.S Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.1.3.1. Hospitals and clinics
11.5.1.3.2. Ambulatory centers
11.5.1.3.3. Urgent care centers
11.5.1.3.4. Speciality Cardiac Centers
11.5.1.3.5. Others
11.5.2. Canada
11.5.2.1. Canada Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
11.5.2.1.1. Mechanical heart valves
11.5.2.1.1.1. Bileaflet
11.5.2.1.1.2. Monoleaflet
11.5.2.1.1.3. Caged ball valves
11.5.2.1.2. Tissue(bioprosthetic) heart valves
11.5.2.1.2.1. Stented
11.5.2.1.2.2. Stentless
11.5.2.1.3. Transcatheter heart valves
11.5.2.2. Canada Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
11.5.2.2.1. Arotic
11.5.2.2.2. Mitral
11.5.2.3. Canada Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.2.3.1. Hospitals and clinics
11.5.2.3.2. Ambulatory centers
11.5.2.3.3. Urgent care centers
11.5.2.3.4. Speciality Cardiac Centers
11.5.2.3.5. Others
11.5.3. Mexico
11.5.3.1. Mexico Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
11.5.3.1.1. Mechanical heart valves
11.5.3.1.1.1. Bileaflet
11.5.3.1.1.2. Monoleaflet
11.5.3.1.1.3. Caged ball valves
11.5.3.1.2. Tissue(bioprosthetic) heart valves
11.5.3.1.2.1. Stented
11.5.3.1.2.2. Stentless
11.5.3.1.3. Transcatheter heart valves
11.5.3.2. Mexico Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
11.5.3.2.1. Arotic
11.5.3.2.2. Mitral
11.5.3.3. Mexico Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.3.3.1. Hospitals and clinics
11.5.3.3.2. Ambulatory centers
11.5.3.3.3. Urgent care centers
11.5.3.3.4. Speciality Cardiac Centers
11.5.3.3.5. Others
11.5.4. Rest of North America
11.5.4.1. Rest of North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
11.5.4.1.1. Mechanical heart valves
11.5.4.1.1.1. Bileaflet
11.5.4.1.1.2. Monoleaflet
11.5.4.1.1.3. Caged ball valves
11.5.4.1.2. Tissue(bioprosthetic) heart valves
11.5.4.1.2.1. Stented
11.5.4.1.2.2. Stentless
11.5.4.1.3. Transcatheter heart valves
11.5.4.2. Rest of North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
11.5.4.2.1. Arotic
11.5.4.2.2. Mitral
11.5.4.3. Rest of North America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.4.3.1. Hospitals and clinics
11.5.4.3.2. Ambulatory centers
11.5.4.3.3. Urgent care centers
11.5.4.3.4. Speciality Cardiac Centers
11.5.4.3.5. Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Type
11.6.3. By Position
11.6.4. By End Users
12. Europe Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Europe Prosthetic Heart Valve Market Revenue (US$ Mn)
12.2. Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. Mechanical heart valves
12.2.1.1. Bileaflet
12.2.1.2. Monoleaflet
12.2.1.3. Caged ball valves
12.2.2. Tissue(bioprosthetic) heart valves
12.2.2.1. Stented
12.2.2.2. Stentless
12.2.3. Transcatheter heart valves
12.3. Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.3.1. Arotic
12.3.2. Mitral
12.4. Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.1. Hospitals and clinics
12.4.2. Ambulatory centers
12.4.3. Urgent care centers
12.4.4. Speciality Cardiac Centers
12.4.5. Others
12.5. Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.1.1.1. Mechanical heart valves
12.5.1.1.1.1. Bileaflet
12.5.1.1.1.2. Monoleaflet
12.5.1.1.1.3. Caged ball valves
12.5.1.1.2. Tissue(bioprosthetic) heart valves
12.5.1.1.2.1. Stented
12.5.1.1.2.2. Stentless
12.5.1.1.3. Transcatheter heart valves
12.5.1.2. France Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.1.2.1. Arotic
12.5.1.2.2. Mitral
12.5.1.3. France Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1.3.1. Hospitals and clinics
12.5.1.3.2. Ambulatory centers
12.5.1.3.3. Urgent care centers
12.5.1.3.4. Speciality Cardiac Centers
12.5.1.3.5. Others
12.5.2. The UK
12.5.2.1. The UK Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.2.1.1. Mechanical heart valves
12.5.2.1.1.1. Bileaflet
12.5.2.1.1.2. Monoleaflet
12.5.2.1.1.3. Caged ball valves
12.5.2.1.2. Tissue(bioprosthetic) heart valves
12.5.2.1.2.1. Stented
12.5.2.1.2.2. Stentless
12.5.2.1.3. Transcatheter heart valves
12.5.2.2. The UK Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.2.2.1. Arotic
12.5.2.2.2. Mitral
12.5.2.3. The UK Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.2.3.1. Hospitals and clinics
12.5.2.3.2. Ambulatory centers
12.5.2.3.3. Urgent care centers
12.5.2.3.4. Speciality Cardiac Centers
12.5.2.3.5. Others
12.5.3. Spain
12.5.3.1. Spain Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.3.1.1. Mechanical heart valves
12.5.3.1.1.1. Bileaflet
12.5.3.1.1.2. Monoleaflet
12.5.3.1.1.3. Caged ball valves
12.5.3.1.2. Tissue(bioprosthetic) heart valves
12.5.3.1.2.1. Stented
12.5.3.1.2.2. Stentless
12.5.3.1.3. Transcatheter heart valves
12.5.3.2. Spain Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.3.2.1. Arotic
12.5.3.2.2. Mitral
12.5.3.3. Spain Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.3.3.1. Hospitals and clinics
12.5.3.3.2. Ambulatory centers
12.5.3.3.3. Urgent care centers
12.5.3.3.4. Speciality Cardiac Centers
12.5.3.3.5. Others
12.5.4. Germany
12.5.4.1. Germany Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.4.1.1. Mechanical heart valves
12.5.4.1.1.1. Bileaflet
12.5.4.1.1.2. Monoleaflet
12.5.4.1.1.3. Caged ball valves
12.5.4.1.2. Tissue(bioprosthetic) heart valves
12.5.4.1.2.1. Stented
12.5.4.1.2.2. Stentless
12.5.4.1.3. Transcatheter heart valves
12.5.4.2. Germany Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.4.2.1. Arotic
12.5.4.2.2. Mitral
12.5.4.3. Germany Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.4.3.1. Hospitals and clinics
12.5.4.3.2. Ambulatory centers
12.5.4.3.3. Urgent care centers
12.5.4.3.4. Speciality Cardiac Centers
12.5.4.3.5. Others
12.5.5. Italy
12.5.5.1. Italy Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.5.1.1. Mechanical heart valves
12.5.5.1.1.1. Bileaflet
12.5.5.1.1.2. Monoleaflet
12.5.5.1.1.3. Caged ball valves
12.5.5.1.2. Tissue(bioprosthetic) heart valves
12.5.5.1.2.1. Stented
12.5.5.1.2.2. Stentless
12.5.5.1.3. Transcatheter heart valves
12.5.5.2. Italy Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.5.2.1. Arotic
12.5.5.2.2. Mitral
12.5.5.3. Italy Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.5.3.1. Hospitals and clinics
12.5.5.3.2. Ambulatory centers
12.5.5.3.3. Urgent care centers
12.5.5.3.4. Speciality Cardiac Centers
12.5.5.3.5. Others
12.5.6. Nordic Countries
12.5.6.1. Nordic Countries Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.6.1.1. Mechanical heart valves
12.5.6.1.1.1. Bileaflet
12.5.6.1.1.2. Monoleaflet
12.5.6.1.1.3. Caged ball valves
12.5.6.1.2. Tissue(bioprosthetic) heart valves
12.5.6.1.2.1. Stented
12.5.6.1.2.2. Stentless
12.5.6.1.3. Transcatheter heart valves
12.5.6.2. Nordic Countries Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.6.2.1. Arotic
12.5.6.2.2. Mitral
12.5.6.3. Nordic Countries Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.6.3.1. Hospitals and clinics
12.5.6.3.2. Ambulatory centers
12.5.6.3.3. Urgent care centers
12.5.6.3.4. Speciality Cardiac Centers
12.5.6.3.5. Others
12.5.6.4. Nordic Countries Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux Union
12.5.7.1. Benelux Union Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.7.1.1. Mechanical heart valves
12.5.7.1.1.1. Bileaflet
12.5.7.1.1.2. Monoleaflet
12.5.7.1.1.3. Caged ball valves
12.5.7.1.2. Tissue(bioprosthetic) heart valves
12.5.7.1.2.1. Stented
12.5.7.1.2.2. Stentless
12.5.7.1.3. Transcatheter heart valves
12.5.7.2. Benelux Union Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.7.2.1. Arotic
12.5.7.2.2. Mitral
12.5.7.3. Benelux Union Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.3.1. Hospitals and clinics
12.5.7.3.2. Ambulatory centers
12.5.7.3.3. Urgent care centers
12.5.7.3.4. Speciality Cardiac Centers
12.5.7.3.5. Others
12.5.7.4. Benelux Union Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of Europe
12.5.8.1. Rest of Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
12.5.8.1.1. Mechanical heart valves
12.5.8.1.1.1. Bileaflet
12.5.8.1.1.2. Monoleaflet
12.5.8.1.1.3. Caged ball valves
12.5.8.1.2. Tissue(bioprosthetic) heart valves
12.5.8.1.2.1. Stented
12.5.8.1.2.2. Stentless
12.5.8.1.3. Transcatheter heart valves
12.5.8.2. Rest of Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
12.5.8.2.1. Arotic
12.5.8.2.2. Mitral
12.5.8.3. Rest of Europe Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.3.1. Hospitals and clinics
12.5.8.3.2. Ambulatory centers
12.5.8.3.3. Urgent care centers
12.5.8.3.4. Speciality Cardiac Centers
12.5.8.3.5. Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Type
12.6.3. By Position
12.6.4. By End Users
13. Asia Pacific Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn)
13.2. Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Mechanical heart valves
13.2.1.1. Bileaflet
13.2.1.2. Monoleaflet
13.2.1.3. Caged ball valves
13.2.2. Tissue(bioprosthetic) heart valves
13.2.2.1. Stented
13.2.2.2. Stentless
13.2.3. Transcatheter heart valves
13.3. Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.3.1. Arotic
13.3.2. Mitral
13.4. Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.1. Hospitals and clinics
13.4.2. Ambulatory centers
13.4.3. Urgent care centers
13.4.4. Speciality Cardiac Centers
13.4.5. Others
13.5. Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.1.1.1. Mechanical heart valves
13.5.1.1.1.1. Bileaflet
13.5.1.1.1.2. Monoleaflet
13.5.1.1.1.3. Caged ball valves
13.5.1.1.2. Tissue(bioprosthetic) heart valves
13.5.1.1.2.1. Stented
13.5.1.1.2.2. Stentless
13.5.1.1.3. Transcatheter heart valves
13.5.1.2. China Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.1.2.1. Arotic
13.5.1.2.2. Mitral
13.5.1.3. China Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1.3.1. Hospitals and clinics
13.5.1.3.2. Ambulatory centers
13.5.1.3.3. Urgent care centers
13.5.1.3.4. Speciality Cardiac Centers
13.5.1.3.5. Others
13.5.2. Japan
13.5.2.1. Japan Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.2.1.1. Mechanical heart valves
13.5.2.1.1.1. Bileaflet
13.5.2.1.1.2. Monoleaflet
13.5.2.1.1.3. Caged ball valves
13.5.2.1.2. Tissue(bioprosthetic) heart valves
13.5.2.1.2.1. Stented
13.5.2.1.2.2. Stentless
13.5.2.1.3. Transcatheter heart valves
13.5.2.2. Japan Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.2.2.1. Arotic
13.5.2.2.2. Mitral
13.5.2.3. Japan Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.2.3.1. Hospitals and clinics
13.5.2.3.2. Ambulatory centers
13.5.2.3.3. Urgent care centers
13.5.2.3.4. Speciality Cardiac Centers
13.5.2.3.5. Others
13.5.3. India
13.5.3.1. India Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.3.1.1. Mechanical heart valves
13.5.3.1.1.1. Bileaflet
13.5.3.1.1.2. Monoleaflet
13.5.3.1.1.3. Caged ball valves
13.5.3.1.2. Tissue(bioprosthetic) heart valves
13.5.3.1.2.1. Stented
13.5.3.1.2.2. Stentless
13.5.3.1.3. Transcatheter heart valves
13.5.3.2. India Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.3.2.1. Arotic
13.5.3.2.2. Mitral
13.5.3.3. India Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.3.3.1. Hospitals and clinics
13.5.3.3.2. Ambulatory centers
13.5.3.3.3. Urgent care centers
13.5.3.3.4. Speciality Cardiac Centers
13.5.3.3.5. Others
13.5.4. New Zealand
13.5.4.1. New Zealand Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.4.1.1. Mechanical heart valves
13.5.4.1.1.1. Bileaflet
13.5.4.1.1.2. Monoleaflet
13.5.4.1.1.3. Caged ball valves
13.5.4.1.2. Tissue(bioprosthetic) heart valves
13.5.4.1.2.1. Stented
13.5.4.1.2.2. Stentless
13.5.4.1.3. Transcatheter heart valves
13.5.4.2. New Zealand Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.4.2.1. Arotic
13.5.4.2.2. Mitral
13.5.4.3. New Zealand Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.4.3.1. Hospitals and clinics
13.5.4.3.2. Ambulatory centers
13.5.4.3.3. Urgent care centers
13.5.4.3.4. Speciality Cardiac Centers
13.5.4.3.5. Others
13.5.5. Australia
13.5.5.1. Australia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.5.1.1. Mechanical heart valves
13.5.5.1.1.1. Bileaflet
13.5.5.1.1.2. Monoleaflet
13.5.5.1.1.3. Caged ball valves
13.5.5.1.2. Tissue(bioprosthetic) heart valves
13.5.5.1.2.1. Stented
13.5.5.1.2.2. Stentless
13.5.5.1.3. Transcatheter heart valves
13.5.5.2. Australia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.5.2.1. Arotic
13.5.5.2.2. Mitral
13.5.5.3. Australia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.5.3.1. Hospitals and clinics
13.5.5.3.2. Ambulatory centers
13.5.5.3.3. Urgent care centers
13.5.5.3.4. Speciality Cardiac Centers
13.5.5.3.5. Others
13.5.6. South Korea
13.5.6.1. South Korea Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.6.1.1. Mechanical heart valves
13.5.6.1.1.1. Bileaflet
13.5.6.1.1.2. Monoleaflet
13.5.6.1.1.3. Caged ball valves
13.5.6.1.2. Tissue(bioprosthetic) heart valves
13.5.6.1.2.1. Stented
13.5.6.1.2.2. Stentless
13.5.6.1.3. Transcatheter heart valves
13.5.6.2. South Korea Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.6.2.1. Arotic
13.5.6.2.2. Mitral
13.5.6.3. South Korea Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.6.3.1. Hospitals and clinics
13.5.6.3.2. Ambulatory centers
13.5.6.3.3. Urgent care centers
13.5.6.3.4. Speciality Cardiac Centers
13.5.6.3.5. Others
13.5.7. Southeast Asia
13.5.7.1. Southeast Asia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.7.1.1. Mechanical heart valves
13.5.7.1.1.1. Bileaflet
13.5.7.1.1.2. Monoleaflet
13.5.7.1.1.3. Caged ball valves
13.5.7.1.2. Tissue(bioprosthetic) heart valves
13.5.7.1.2.1. Stented
13.5.7.1.2.2. Stentless
13.5.7.1.3. Transcatheter heart valves
13.5.7.2. Southeast Asia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.7.2.1. Arotic
13.5.7.2.2. Mitral
13.5.7.3. Southeast Asia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.3.1. Hospitals and clinics
13.5.7.3.2. Ambulatory centers
13.5.7.3.3. Urgent care centers
13.5.7.3.4. Speciality Cardiac Centers
13.5.7.3.5. Others
13.5.7.4. Southeast Asia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1. Rest of Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
13.5.8.1.1. Mechanical heart valves
13.5.8.1.1.1. Bileaflet
13.5.8.1.1.2. Monoleaflet
13.5.8.1.1.3. Caged ball valves
13.5.8.1.2. Tissue(bioprosthetic) heart valves
13.5.8.1.2.1. Stented
13.5.8.1.2.2. Stentless
13.5.8.1.3. Transcatheter heart valves
13.5.8.2. Rest of Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
13.5.8.2.1. Arotic
13.5.8.2.2. Mitral
13.5.8.3. Rest of Asia Pacific Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.8.3.1. Hospitals and clinics
13.5.8.3.2. Ambulatory centers
13.5.8.3.3. Urgent care centers
13.5.8.3.4. Speciality Cardiac Centers
13.5.8.3.5. Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Type
13.6.3. By Position
13.6.4. By End Users
14. Middle East and Africa Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Middle East and Africa Prosthetic Heart Valve Market Revenue (US$ Mn)
14.2. Middle East and Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Mechanical heart valves
14.2.1.1. Bileaflet
14.2.1.2. Monoleaflet
14.2.1.3. Caged ball valves
14.2.2. Tissue(bioprosthetic) heart valves
14.2.2.1. Stented
14.2.2.2. Stentless
14.2.3. Transcatheter heart valves
14.3. Middle East and Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.3.1. Arotic
14.3.2. Mitral
14.4. Middle East and Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.4.1. Hospitals and clinics
14.4.2. Ambulatory centers
14.4.3. Urgent care centers
14.4.4. Speciality Cardiac Centers
14.4.5. Others
14.5. Middle East and Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1. Saudi Arabia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.5.1.1.1. Mechanical heart valves
14.5.1.1.1.1. Bileaflet
14.5.1.1.1.2. Monoleaflet
14.5.1.1.1.3. Caged ball valves
14.5.1.1.2. Tissue(bioprosthetic) heart valves
14.5.1.1.2.1. Stented
14.5.1.1.2.2. Stentless
14.5.1.1.3. Transcatheter heart valves
14.5.1.2. Saudi Arabia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.5.1.2.1. Arotic
14.5.1.2.2. Mitral
14.5.1.3. Saudi Arabia Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.3.1. Hospitals and clinics
14.5.1.3.2. Ambulatory centers
14.5.1.3.3. Urgent care centers
14.5.1.3.4. Speciality Cardiac Centers
14.5.1.3.5. Others
14.5.2. UAE
14.5.2.1. UAE Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.5.2.1.1. Mechanical heart valves
14.5.2.1.1.1. Bileaflet
14.5.2.1.1.2. Monoleaflet
14.5.2.1.1.3. Caged ball valves
14.5.2.1.2. Tissue(bioprosthetic) heart valves
14.5.2.1.2.1. Stented
14.5.2.1.2.2. Stentless
14.5.2.1.3. Transcatheter heart valves
14.5.2.2. UAE Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.5.2.2.1. Arotic
14.5.2.2.2. Mitral
14.5.2.3. UAE Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.2.3.1. Hospitals and clinics
14.5.2.3.2. Ambulatory centers
14.5.2.3.3. Urgent care centers
14.5.2.3.4. Speciality Cardiac Centers
14.5.2.3.5. Others
14.5.3. Egypt
14.5.3.1. Egypt Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.5.3.1.1. Mechanical heart valves
14.5.3.1.1.1. Bileaflet
14.5.3.1.1.2. Monoleaflet
14.5.3.1.1.3. Caged ball valves
14.5.3.1.2. Tissue(bioprosthetic) heart valves
14.5.3.1.2.1. Stented
14.5.3.1.2.2. Stentless
14.5.3.1.3. Transcatheter heart valves
14.5.3.2. Egypt Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.5.3.2.1. Arotic
14.5.3.2.2. Mitral
14.5.3.3. Egypt Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.3.3.1. Hospitals and clinics
14.5.3.3.2. Ambulatory centers
14.5.3.3.3. Urgent care centers
14.5.3.3.4. Speciality Cardiac Centers
14.5.3.3.5. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.5.4.1.1. Mechanical heart valves
14.5.4.1.1.1. Bileaflet
14.5.4.1.1.2. Monoleaflet
14.5.4.1.1.3. Caged ball valves
14.5.4.1.2. Tissue(bioprosthetic) heart valves
14.5.4.1.2.1. Stented
14.5.4.1.2.2. Stentless
14.5.4.1.3. Transcatheter heart valves
14.5.4.2. Kuwait Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.5.4.2.1. Arotic
14.5.4.2.2. Mitral
14.5.4.3. Kuwait Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.4.3.1. Hospitals and clinics
14.5.4.3.2. Ambulatory centers
14.5.4.3.3. Urgent care centers
14.5.4.3.4. Speciality Cardiac Centers
14.5.4.3.5. Others
14.5.5. South Africa
14.5.5.1. South Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.5.5.1.1. Mechanical heart valves
14.5.5.1.1.1. Bileaflet
14.5.5.1.1.2. Monoleaflet
14.5.5.1.1.3. Caged ball valves
14.5.5.1.2. Tissue(bioprosthetic) heart valves
14.5.5.1.2.1. Stented
14.5.5.1.2.2. Stentless
14.5.5.1.3. Transcatheter heart valves
14.5.5.2. South Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.5.5.2.1. Arotic
14.5.5.2.2. Mitral
14.5.5.3. South Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.3.1. Hospitals and clinics
14.5.5.3.2. Ambulatory centers
14.5.5.3.3. Urgent care centers
14.5.5.3.4. Speciality Cardiac Centers
14.5.5.3.5. Others
14.5.6. Rest of Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
14.5.6.1.1. Mechanical heart valves
14.5.6.1.1.1. Bileaflet
14.5.6.1.1.2. Monoleaflet
14.5.6.1.1.3. Caged ball valves
14.5.6.1.2. Tissue(bioprosthetic) heart valves
14.5.6.1.2.1. Stented
14.5.6.1.2.2. Stentless
14.5.6.1.3. Transcatheter heart valves
14.5.6.2. Rest of Middle East & Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
14.5.6.2.1. Arotic
14.5.6.2.2. Mitral
14.5.6.3. Rest of Middle East & Africa Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.6.3.1. Hospitals and clinics
14.5.6.3.2. Ambulatory centers
14.5.6.3.3. Urgent care centers
14.5.6.3.4. Speciality Cardiac Centers
14.5.6.3.5. Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Type
14.6.3. By Position
14.6.4. By End Users
15. Latin America Prosthetic Heart Valve Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Latin America Prosthetic Heart Valve Market Revenue (US$ Mn)
15.2. Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Mechanical heart valves
15.2.1.1. Bileaflet
15.2.1.2. Monoleaflet
15.2.1.3. Caged ball valves
15.2.2. Tissue(bioprosthetic) heart valves
15.2.2.1. Stented
15.2.2.2. Stentless
15.2.3. Transcatheter heart valves
15.3. Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
15.3.1. Arotic
15.3.2. Mitral
15.4. Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
15.4.1. Hospitals and clinics
15.4.2. Ambulatory centers
15.4.3. Urgent care centers
15.4.4. Speciality Cardiac Centers
15.4.5. Others
15.5. Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
15.5.1.1.1. Mechanical heart valves
15.5.1.1.1.1. Bileaflet
15.5.1.1.1.2. Monoleaflet
15.5.1.1.1.3. Caged ball valves
15.5.1.1.2. Tissue(bioprosthetic) heart valves
15.5.1.1.2.1. Stented
15.5.1.1.2.2. Stentless
15.5.1.1.3. Transcatheter heart valves
15.5.1.2. Brazil Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
15.5.1.2.1. Arotic
15.5.1.2.2. Mitral
15.5.1.3. Brazil Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1.3.1. Hospitals and clinics
15.5.1.3.2. Ambulatory centers
15.5.1.3.3. Urgent care centers
15.5.1.3.4. Speciality Cardiac Centers
15.5.1.3.5. Others
15.5.2. Argentina
15.5.2.1. Argentina Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
15.5.2.1.1. Mechanical heart valves
15.5.2.1.1.1. Bileaflet
15.5.2.1.1.2. Monoleaflet
15.5.2.1.1.3. Caged ball valves
15.5.2.1.2. Tissue(bioprosthetic) heart valves
15.5.2.1.2.1. Stented
15.5.2.1.2.2. Stentless
15.5.2.1.3. Transcatheter heart valves
15.5.2.2. Argentina Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
15.5.2.2.1. Arotic
15.5.2.2.2. Mitral
15.5.2.3. Argentina Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.2.3.1. Hospitals and clinics
15.5.2.3.2. Ambulatory centers
15.5.2.3.3. Urgent care centers
15.5.2.3.4. Speciality Cardiac Centers
15.5.2.3.5. Others
15.5.3. Rest of Latin America
15.5.3.1. Rest of Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Type
15.5.3.1.1. Mechanical heart valves
15.5.3.1.1.1. Bileaflet
15.5.3.1.1.2. Monoleaflet
15.5.3.1.1.3. Caged ball valves
15.5.3.1.2. Tissue(bioprosthetic) heart valves
15.5.3.1.2.1. Stented
15.5.3.1.2.2. Stentless
15.5.3.1.3. Transcatheter heart valves
15.5.3.2. Rest of Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By Position
15.5.3.2.1. Arotic
15.5.3.2.2. Mitral
15.5.3.3. Rest of Latin America Prosthetic Heart Valve Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.3.3.1. Hospitals and clinics
15.5.3.3.2. Ambulatory centers
15.5.3.3.3. Urgent care centers
15.5.3.3.4. Speciality Cardiac Centers
15.5.3.3.5. Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Type
15.6.3. By Position
15.6.4. By End Users
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2020
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Abbott
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Braile Biomédica
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Colibri Heart Valve
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. CryoLife, Inc
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Edwards Lifesciences Corporation
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. JenaValve Technology, Inc
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Labcor
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. LivaNova PLC( Gyprus Capital)
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Medtronic
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7.
Business
Strategies
17.10. Other Market Participants
18. Key Findings
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.